According to Agenus
's latest financial reports the company's current revenue (TTM) is $0.16 B.
In 2022 the company made a revenue of $98.02 M a decrease over the years 2021 revenue that were of $0.29 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.15 B | 59.46% |
2022 | $98.02 M | -66.85% |
2021 | $0.29 B | 235.34% |
2020 | $88.16 M | -41.24% |
2019 | $0.15 B | 307.92% |
2018 | $36.78 M | -14.21% |
2017 | $42.87 M | 89.95% |
2016 | $22.57 M | -9.04% |
2015 | $24.81 M | 255.67% |
2014 | $6.97 M | 129.13% |
2013 | $3.04 M | -80.92% |
2012 | $15.96 M | 479.17% |
2011 | $2.75 M | -17.97% |
2010 | $3.35 M | 0.75% |
2009 | $3.33 M | 25.78% |
2008 | $2.65 M | -52.25% |
2007 | $5.55 M | 702.2% |
2006 | $0.69 M | 9.87% |
2005 | $0.62 M | -10.9% |
2004 | $0.7 M | -79.96% |
2003 | $3.52 M | 3.41% |
2002 | $3.41 M | -25.1% |
2001 | $4.55 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $89.65 B | 55,445.30% | ๐บ๐ธ USA |
![]() Merck MRK | $61.40 B | 37,939.60% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | $45.53 B | 28,109.10% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | $38.54 B | 23,778.35% | ๐ฌ๐ง UK |
![]() Celldex Therapeutics CLDX | $6.07 M | -96.24% | ๐บ๐ธ USA |